Genekam making ready
for Nasdaq IPO 2024
The results of the above conference are as follows: 17 meetings were confirmed. 14 meetings with investment banks and investors took place. Now we have to do the follow up these meeting with investment banks and investors to see the final results.
Herausgeber
Genekam Biotechnology AG
Duissern Str. 65a
47058 Duisburg
Sitz der Gesellschaft und des Registergerichts
Duisburg Genekam Biotechnology
HRB-Nr.: 8345